Dean A. Fennell

Lancaster Road
Leicester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.

Journal: Oncogenesis

Published: June 18, 2026

Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].

Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 13, 2026

Mesothelioma: a systemic therapy clinical trials snapshot.

Mesothelioma: a systemic therapy clinical trials snapshot.

Journal: Trends in cancer

Published: December 18, 2025

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Journal: The Lancet. Oncology

Published: October 15, 2025

Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.

Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 13, 2025

BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities.

BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities.

Journal: Oncogene

Published: September 12, 2025

Pleural mesothelioma.

Pleural mesothelioma.

Journal: Nature reviews. Disease primers

Published: July 14, 2025

Evolutionary characterization of lung cancer metastasis.

Evolutionary characterization of lung cancer metastasis.

Journal: Nature

Published: June 29, 2025

Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma.

Discovery of actionable drug targets to enhance T-cell infiltration and immune checkpoint blockade efficacy in pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 27, 2025

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

Journal: Nature communications

Published: June 01, 2025

Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction.

Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction.

Journal: Cell

Published: February 23, 2025

The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma.

The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma.

Journal: Cancer treatment and research communications

Published: October 21, 2024

Showing 1-12 of 130

Last Updated: 09/26/2026